Evidence map›Paper›PMID 25383320›Full record

ArticleTranslational andrology and urology2014

Cystine nephrolithiasis.

Hasan Fattah, Yasmin Hambaroush, David S Goldfarb

Open access · greenAbstract read
In one paragraph

Article in Translational andrology and urology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Cystinuria: urine sediment as a diagnostic test.Advances in laboratory medicine · 2020
    Article
  7. Article
  8. Article
  9. Amino Acid Transport Defects in Human Inherited Metabolic Disorders.International journal of molecular sciences · 2019
    Review
  10. Article
  11. Review
  12. Review
  13. Clinical and genetic analysis of patients with cystinuria in the United Kingdom.Clinical journal of the American Society of Nephrology : CJASN · 2015
    Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hasan FattahNephrology Section, New York Harbor VA Healthcare System, New York, NY, USA ; Nephrology Division, NYU Langone Medical Center, New York, NY, USA.
Yasmin HambaroushNephrology Section, New York Harbor VA Healthcare System, New York, NY, USA ; Nephrology Division, NYU Langone Medical Center, New York, NY, USA.
David S GoldfarbNephrology Section, New York Harbor VA Healthcare System, New York, NY, USA ; Nephrology Division, NYU Langone Medical Center, New York, NY, USA.
VA NY Harbor Healthcare System · US

Funding

Primary HyperoxaluriaU54DK083908 · NIDDK · MAYO CLINIC ROCHESTER · PI MILLINER, DAWN SCHMAUTZ · 2009 to 2018
$12.3M
NIDDK NIH HHS U54 DK083908
6 · The paper itself

Abstract

Our understanding of the molecular basis of cystinuria has deepened as the result of the causative genes,

Indexed as

CystinuriaD-penicillaminekidney stonestioproninurolithiasis

Identifiers

PMID25383320
PMCPMC4220544
OpenAlexW4292524799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.